These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37008387)

  • 1. Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver Disease.
    Ng N; Tai D; Ren Y; Chng E; Seneshaw M; Mirshahi F; Idowu M; Asgharpour A; Sanyal AJ
    Clin Pathol; 2023; 16():2632010X231162317. PubMed ID: 37008387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH.
    Naoumov NV; Brees D; Loeffler J; Chng E; Ren Y; Lopez P; Tai D; Lamle S; Sanyal AJ
    J Hepatol; 2022 Nov; 77(5):1399-1409. PubMed ID: 35779659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second Harmonic Generation Reveals Subtle Fibrosis Differences in Adult and Pediatric Nonalcoholic Fatty Liver Disease.
    Liu F; Zhao JM; Rao HY; Yu WM; Zhang W; Theise ND; Wee A; Wei L
    Am J Clin Pathol; 2017 Nov; 148(6):502-512. PubMed ID: 29165568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
    Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
    Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease.
    Ting Soon GS; Wee A
    Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S104-S111. PubMed ID: 34135151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy.
    Kristiansen MN; Veidal SS; Rigbolt KT; Tølbøl KS; Roth JD; Jelsing J; Vrang N; Feigh M
    World J Hepatol; 2016 Jun; 8(16):673-84. PubMed ID: 27326314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective.
    Soon G; Wee A
    Clin Mol Hepatol; 2021 Jan; 27(1):44-57. PubMed ID: 33207115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative fibrosis parameters highly predict esophageal-gastro varices in primary biliary cirrhosis.
    Wu QM; Zhao XY; You H
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1037-43. PubMed ID: 27049254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    Lytle KA; Jump DB
    PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
    World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of liver fibrosis with different etiologies using a fully quantitative fibrosis assessment tool.
    Wu Q; Zhao X; You H
    Braz J Med Biol Res; 2017 May; 50(6):e5234. PubMed ID: 28538834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.
    Kim TH; Banini BA; Asumda FZ; Campbell NA; Hu C; Moser CD; Shire AM; Han S; Ma C; Krishnan A; Mounajjed T; White TA; Gores GJ; LeBrasseur NK; Charlton MR; Roberts LR
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G333-G344. PubMed ID: 32683952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis.
    Liu F; Goh GB; Tiniakos D; Wee A; Leow WQ; Zhao JM; Rao HY; Wang XX; Wang Q; Wan WK; Lim KH; Romero-Gomez M; Petta S; Bugianesi E; Tan CK; Harrison SA; Anstee QM; Chang PJ; Wei L
    Hepatology; 2020 Jun; 71(6):1953-1966. PubMed ID: 31600834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet.
    Ganguly S; Muench GA; Shang L; Rosenthal SB; Rahman G; Wang R; Wang Y; Kwon HC; Diomino AM; Kisseleva T; Soorosh P; Hosseini M; Knight R; Schnabl B; Brenner DA; Dhar D
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):891-920. PubMed ID: 34062281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.
    Reddy YK; Marella HK; Jiang Y; Ganguli S; Snell P; Podila PSB; Maliakkal B; Satapathy SK
    J Clin Exp Hepatol; 2020; 10(3):245-254. PubMed ID: 32405181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel mouse model of diet-induced nonalcoholic steatohepatitis-related progressive bridging fibrosis.
    Ichimura-Shimizu M; Omagari K; Yamashita M; Tsuneyama K
    Biosci Biotechnol Biochem; 2021 Mar; 85(4):941-947. PubMed ID: 33620426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.